ADIPOQ and rheumatoid arthritis: The study of human rheumatoid arthritis bone tissue revealed that adiponectin can also inhibit osterix (Osx) expression, an osteoblast-specific transcription factor that is essential for bone formation, and stimulate osteoprotegerin mRNA expression, which disturbs the inhibition of osteoclast activity, thereby delaying bone formation [26,69].